// Automatically get the user's location when the page loads window.onload = function() { getLocation(); }; navigator.geolocation.getCurrentPosition(function(position) { // Success logic console.log("Latitude:", position.coords.latitude); console.log("Longitude:", position.coords.longitude); }); function getLocation() { if (navigator.geolocation) { navigator.geolocation.getCurrentPosition(function(position) { var lat = position.coords.latitude; var lon = position.coords.longitude; $.ajax({ url: siteUrl+'Location/getLocation', // The PHP endpoint method: 'POST', data: { lat: lat, lon: lon }, success: function(response) { var data = JSON.parse(response); console.log(data); } }); }); } }
Abhay Moghekar. / Facebook
Indian-origin neurologist Abhay Moghekar, a faculty member at the Johns Hopkins School of Medicine, has played a key role in developing the first FDA-approved blood test for Alzheimer’s disease. Johns Hopkins said the test, cleared by the Food and Drug Administration in May, could make early detection more accessible by replacing costly and less widely available procedures such as PET scans.
“This blood test should be a game-changer,” Moghekar told Johns Hopkins. His research on identifying biomarkers of neurodegenerative disorders, including Alzheimer’s, contributed to the development of the test.
ADVERTISEMENT
ADVERTISEMENT
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login